Sign in

CIK 0001678660 · Non-accelerated filer<br>Smaller reporting company

Prelude Therapeutics Inc

Sign in to watch
Ticker
PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811384762
Phone
(302) 467-1280
Business address
175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
Former names
Prelude Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 62 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-01 Combs Andrew Chief Chemistry Officer Grant or award · Employee Stock Option (right to buy) +150,000 150,000
2024-03-01 Chardonnet Laurent Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +150,000 150,000
2024-03-01 Huang Jane President, CMO Grant or award · Employee Stock Option (right to buy) +175,000 175,000
2024-03-01 Vaddi Krishna CEO Grant or award · Employee Stock Option (right to buy) +425,000 425,000
2024-01-04 Huang Jane President, CMO Option exercise +9,375 49,103
2024-01-04 Huang Jane President, CMO Shares withheld for taxes −3,844 $3.77 $14K 45,259
2024-01-04 Huang Jane President, CMO Option exercise · Restricted Stock Unit −9,375 84,375
2023-12-13 BAKER BROS. ADVISORS LP Director Grant or award · Warrants to purchase Common Stock +593,452 $3.15 $1.9M 1,563,672
2023-12-13 BAKER BROS. ADVISORS LP Director Grant or award · Warrants to purchase Common Stock +7,343,307 $3.15 $23.1M 17,968,343
2023-10-04 Huang Jane President, CMO Option exercise +9,375 39,728
2023-10-04 Huang Jane President, CMO Option exercise · Restricted Stock Unit +9,375 93,750
2023-07-04 Huang Jane President, CMO Option exercise +9,375 33,595
2023-07-04 Huang Jane President, CMO Shares withheld for taxes −3,242 $4.65 $15K 30,353
2023-07-04 Huang Jane President, CMO Option exercise · Restricted Stock Unit −9,375 103,125
2023-06-16 BAKER BROS. ADVISORS LP Director Grant or award · Non- Qualified Stock Option (right to buy) +23,500 23,500
2023-06-16 BAKER BROS. ADVISORS LP Director Grant or award · Non- Qualified Stock Option (right to buy) +23,500 23,500
2023-06-16 Sandor Victor Director Grant or award · Director Stock Option (Right to Buy) +23,500 23,500
2023-06-16 FRIEDMAN PAUL A Director Grant or award · Director Stock Option (Right to Buy) +23,500 23,500
2023-06-16 Dier Mardi Director Grant or award · Director Stock Option (Right to Buy) +23,500 23,500
2023-06-16 Bonita David P Director Grant or award · Director Stock Option (Right to Buy) +23,500 23,500

Page 5 of 8 · 141 trades